Navigation Links
Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
Date:12/12/2008

of patients with hepatitis C."

The approval of PEGINTRON for the pediatric indication is based on the results of a clinical trial in 107 previously untreated patients 3 to 17 years of age with chronic hepatitis C and compensated liver disease. In the study, patients infected with HCV genotype 1 or 4 and those with HCV genotype 3 with HCV RNA greater than 600,000 IU/mL (high viral load [HVL]) were assigned 48 weeks of therapy, while those infected with HCV genotype 2 or 3 with HCV RNA less than 600,000 IU/mL (low viral load [LVL]) received 24 weeks of therapy. Of the patients with HCV genotype 1, 4 or 3 HVL who were assigned to 48 weeks of treatment, 55 percent achieved SVR. As with adult patients, SVR in pediatric patients with HCV genotype 2 or 3 LVL was much higher than in those with genotype 1; the SVR rate was 96 percent in children with HCV genotype 2 or 3 LVL.

In the pediatric population, the recommended dose of PEGINTRON, based on body surface area, is 60 mcg/m2/week subcutaneously in combination with 15 mg/kg/day of REBETOL, based on body weight, orally in two divided doses. The treatment duration for patients with HCV genotype 1 is 48 weeks and for patients with HCV genotype 2 or 3 it is 24 weeks. Patients receiving PEGINTRON combination therapy (excluding those with HCV genotype 2 or 3) should be discontinued from therapy at week 12 if their HCV RNA dropped less than 2 log10 compared to pretreatment or at 24 weeks if they have detectable HCV RNA at treatment week 24.

During the course of therapy lasting up to 48 weeks in patients 3 to 17 years of age, weight loss and growth inhibition were common. Some children who experienced growth inhibition during therapy still had inhibited growth velocity 6 months following the end of treatment. Most common adverse reactions (more than 25 percent) observed in these studies were pyrexia, headache, neutropenia, fatigue, anorexia, injection site ery
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
2. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
3. Schering-Plough Reports Financial Results for Third Quarter of 2007
4. Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
5. Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case
6. Schering-Plough to Webcast CFO Robert J. Bertolinis Presentation at 2007 Credit Suisse Health Care Conference
7. Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
8. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
9. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
10. Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
11. Schering-Plough CEO to Buy $2 Million in Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... KY (PRWEB) May 18, 2013 During ... hearing loss should consider the legal protections they have, ... when problems arise with their child’s treatment or hearing ... , Since 1927, the American Speech-Language-Hearing Association has used ... disorders and to promote treatment, such as cochlear implants, ...
(Date:5/18/2013)... Rosa, CA (PRWEB) May 18, 2013 ... . The simple to read reviews and comprehensive comparisons ... and impartial home security reviews. 6Webs.com just recently finished ... alarm system providers. , Tim Smythe from 6Webs.com reports, ... security systems due to their ease of use, expandability ...
(Date:5/18/2013)... The California College of Ayurveda Spa is ... Ayurvedic Spa , the client receives stress relief therapies ... lifestyle recommendations and stress management techniques by a Clinical ... traditional healthcare system of India. It is based on ... basis for all optimum health. Ayurveda believes that where ...
(Date:5/18/2013)... Dr. Robert Tracey, an area leader in ... his knowledge of the root causes of sleep apnea to ... being Better Sleep Month, Dr. Tracey points out estimates revealing ... disorder, and sleep apnea is one of the most common ... essentially stop breathing at different times while sleeping. When this ...
(Date:5/18/2013)... 2013 John Ravera, D.D.S., a Newport ... a new member to his dental team, Courtney Marino. , ... field for over 10 years. She received her degree from ... elected a member of Sigma Pi Alpha, a national honor ... working with patients of all ages, helping them understand the ...
Breaking Medicine News(10 mins):Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2
... be able to access hidden wisdom in the brain ... and safety, UCLA neuroscientists report in the first study ... will respond to advertisements. Thirty smokers ... three advertising campaigns, which all ended by showing the ...
... West Orange, NJ. April 25, 2012. American Spinal Injury ... the article by Mark Nash, PhD, et al, entitled, ... treating dyslipidemia risks in persons with chronic tetraplegia: a ... published in Archives of Physical Medicine and Rehabilitation ...
... , WEDNESDAY, April 25 (HealthDay News) -- A lack ... the loss of a loved one, abuse and sexual assault ... People with eating disorders said even changing schools or jobs ... to the University of Minnesota researchers. The study included ...
... News) -- Air quality in America,s most polluted cities has ... report from the American Lung Association. Even Los Angeles, ... in 13 years, the association noted. Santa Fe, N.M. leads ... the nation. Despite progress in reducing the level of ...
... go to mature? Neural stem cells have this problem, too. ... in a protected environment called a niche in order to divide ... nervous system. But when it,s time to mature, or differentiate, the ... migrate to where they are needed to form the circuits necessary ...
... scans of a small group of people can predict the ... researchers from the University of Michigan, the University of Oregon ... findings are relevant to political advertising, commercial market research and ... from a diagnostic to a predictive tool. As opposed ...
Cached Medicine News:Health News:Which ads are winners? Your brain knows better than you do 2Health News:Which ads are winners? Your brain knows better than you do 3Health News:Which ads are winners? Your brain knows better than you do 4Health News:Spinal cord injury researchers win Apple Award for article on niacin for dyslipidemia 2Health News:Life Transitions May Trigger Eating Disorders 2Health News:Air Quality Improving in Many U.S. Cities: Report 2Health News:Air Quality Improving in Many U.S. Cities: Report 3Health News:Growing up as a neural stem cell: The importance of clinging together and then letting go 2Health News:Growing up as a neural stem cell: The importance of clinging together and then letting go 3Health News:Small 'neural focus groups' predict anti-smoking ad success 2Health News:Small 'neural focus groups' predict anti-smoking ad success 3
(Date:5/16/2013)... YORK , May 16, 2013 Developers of ... sends patient reminders have emerged as grand prize winners in ... innovation challenge funded by Boehringer Ingelheim and organized by ... Stein , John Langhauser and ... from the United States will ...
(Date:5/16/2013)... 16, 2013  Actinium Pharmaceuticals, Inc. (OTCBB: ... targeted payload immunotherapeutics for treatment of advanced ... TAT: Target Alpha Therapy (TAT) international symposium ... Pharmaceuticals, clinical programs.  The abstract entitled "Alpha-Particle ... and Actinium-225" has been accepted for oral ...
(Date:5/16/2013)... 16, 2013  Lakewood-Amedex Inc., a leading developer ... recent series of in vitro studies ... of antimicrobials, named bisphosphocins, function through a completely ... resulting in rapid direct bacterial killing.  These studies ... be superior to ciprofloxacin.  The studies revealed the ...
Breaking Medicine Technology:Wireless Pill Bottle Wins Healthcare Innovation World Cup 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 3Wireless Pill Bottle Wins Healthcare Innovation World Cup 4Wireless Pill Bottle Wins Healthcare Innovation World Cup 5Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 2Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference 3Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 2Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 3Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials 4
... 4, 2010 Generex Biotechnology Corporation ( www.generex.com ) ... that trades in its common stock are now quoted ... GNBT.OB.  As Generex is in full compliance with its ... stock is eligible for an OTCBB quotation.  The OTCBB ...
... 2010 GeoVax Labs, Inc. (OTCQB/OTC Bulletin Board: ... developing vaccines that prevent and fight Human Immunodeficiency Virus ... a grant of $244,500 related to its HIV/AIDS vaccine ... program. GeoVax received the maximum level allowable under the ...
Cached Medicine Technology:Generex Common Stock Now Quoted on the Over-the-Counter Bulletin Board 2Generex Common Stock Now Quoted on the Over-the-Counter Bulletin Board 3GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program 2GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program 3
... simplified operations, the Sysmex KX-21N is ... satellite lab testing. This 3-part ... Built on the reliable, field ... features a completely automatic START-UP function ...
Immunoassay for the detection of Group A streptococcal antigen directly from throat swab specimens. ,Rapid, accurate diagnosis assures prompt treatment....
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
... Inverness Medical Ovulation Test Kits help you plan ... predictor sticks to help you predict your most ... quickly and accurately detect the increase in luteinizing ... occurs 24 to 48 hours before ovulation. You ...
Medicine Products: